346
Views
4
CrossRef citations to date
0
Altmetric
Articles

Bioinspired silk fibroin nano-delivery systems protect against 5-FU induced gastrointestinal mucositis in a mouse model and display antitumor effects on HT-29 colorectal cancer cells in vitro

, , ORCID Icon, , , , , , , , , ORCID Icon & show all
Pages 973-994 | Received 25 Mar 2021, Accepted 10 Jun 2021, Published online: 02 Jul 2021

References

  • Aggarwal, V., H. S. Tuli, A. Varol, F. Thakral, M. B. Yerer, K. Sak, M. Varol, A. Jain, M. Khan, and G. Sethi. 2019. “Role of Reactive Oxygen Species in Cancer Progression: molecular Mechanisms and Recent Advancements.” Biomolecules 9 (11): 735. doi:10.3390/biom9110735.
  • Ahn, Daniel H., Christina Wu, Lai Wei, Terence M. Williams, Evan Wuthrick, Sherif Abdel-Misih, Alan Harzman, et al. 2017. “The Efficacy of Adjuvant Chemotherapy in Patients with Stage II/III Resected Rectal Cancer Treated with Neoadjuvant Chemoradiation Therapy.” American Journal of Clinical Oncology 40 (6): 531–534. doi:10.1097/COC.0000000000000185.
  • Al Obeed, O. A., K. A. Alkhayal, A. Al Sheikh, A. M. Zubaidi, M. A. Vaali-Mohammed, R. Boushey, J. H. Mckerrow, and M. H. Abdulla. 2014. “Increased Expression of Tumor Necrosis Factor-α Is Associated with Advanced Colorectal Cancer Stages.” World Journal of Gastroenterology 20 (48): 18390–18396. doi:10.3748/wjg.v20.i48.18390.
  • Aragao-Santiago, L., H. Hillaireau, N. Grabowski, S. Mura, T. L. Nascimento, S. Dufort, J. L. Coll, N. Tsapis, and E. Fattal. 2016. “Compared in vivo Toxicity in Mice of Lung Delivered Biodegradable and Non-Biodegradable Nanoparticles.” Nanotoxicology 10 (3): 292–302. doi:10.3109/17435390.2015.1054908.
  • Barcelo, A., J. Claustre, F. Moro, J. Chayvialle, J. Cuber, and P. Plaisancié. 2000. “Mucin Secretion is Modulated by Luminal Factors in the Isolated Vascularly Perfused Rat Colon.” Gut 46 (2): 218–224. doi:10.1136/gut.46.2.218.
  • Cai, B., P. Wan, H. Sun, D. Chen, H. Chen, X. Chen, and J. Pan. 2018. “Protective Effects of Enteral Nutrition Supplemented with Crassostrea hongkongensis Polysaccharides against 5-Fluorouracil-Induced Intestinal Mucosal Damage in Rats.” Journal of Medicinal Food 21 (4): 348–355. doi:10.1089/jmf.2017.4025.
  • Cheah, K. Y., G. S. Howarth, and S. E. Bastian. 2014. “Grape Seed Extract Dose-Responsively Decreases Disease Severity in a Rat Model of Mucositis; Concomitantly Enhancing Chemotherapeutic Effectiveness in Colon Cancer Cells.” PLOS One 9 (1): e85184. doi:10.1371/journal.pone.0085184.
  • Cheah, K. Y., G. S. Howarth, R. Yazbeck, T. H. Wright, E. J. Whitford, C. Payne, R. N. Butler, and S. E. Bastian. 2009. “Grape Seed Extract Protects IEC-6 Cells from Chemotherapy-Induced Cytotoxicity and Improves Parameters of Small Intestinal Mucositis in Rats with Experimentally-Induced Mucositis.” Cancer Biology & Therapy 8 (4): 382–390. doi:10.4161/cbt.8.4.7453.
  • Denham, J. W., and R. L. Abbott. 1991. “Concurrent Cisplatin, Infusional Fluorouracil, and Conventionally Fractionated Radiation Therapy in Head and Neck Cancer: Dose-Limiting Mucosal Toxicity.” Journal of Clinical Oncology 9 (3): 458–463. doi:10.1200/JCO.1991.9.3.458.
  • Duncan, M., and G. Grant. 2003. “Oral and Intestinal Mucositis – Causes and Possible Treatments.” Alimentary Pharmacology & Therapeutics 18 (9): 853–874. doi:10.1046/j.1365-2036.2003.01784.x.
  • Enari, M., H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, and S. Nagata. 1998. “A Caspase-Activated DNase That Degrades DNA during Apoptosis, and Its Inhibitor ICAD.” Nature 391 (6662): 43–50. doi:10.1038/34112.
  • Fonseca, A. C., P. Ferreira, R. A. Cordeiro, P. V. Mendonça, J. R. Góis, M. H. Gil, and J. F. Coelho. 2013. “Drug Delivery Systems for Predictive Medicine: Polymers as Tools for Advanced Applications. In New Strategies to Advance Pre/Diabetes Care: Integrative Approach by PPPM, 399–455. Springer.
  • Gao, Y., R. Yang, Z. Zhang, L. Chen, Z. Sun, and Y. Li. 2011. “Solid Lipid Nanoparticles Reduce Systemic Toxicity of Docetaxel: performance and Mechanism in Animal.” Nanotoxicology 5 (4): 636–649. doi:10.3109/17435390.2010.551427.
  • Gerecke, Christian, Alexander Edlich, Michael Giulbudagian, Fabian Schumacher, Nan Zhang, Andre Said, Guy Yealland, et al. 2017. “Biocompatibility and Characterization of Polyglycerol-Based Thermoresponsive Nanogels Designed as Novel Drug-Delivery Systems and Their Intracellular Localization in Keratinocytes.” Nanotoxicology 11 (2): 267–277. doi:10.1080/17435390.2017.1292371.
  • Ginghină, O., A. Hudiță, C. Zaharia, A. Tsatsakis, Y. Mezhuev, M. Costache, and B. Gălățeanu. 2021. Current. “Landscape in Organic Nanosized Materials Advances for Improved Management of Colorectal Cancer Patients.” Materials 14 (9): 2440.
  • Gou, S., Y. Huang, J. Sung, B. Xiao, and D. Merlin. 2019. “Silk Fibroin-Based Nanotherapeutics: Application in the Treatment of Colonic Diseases.” Nanomedicine 14 (17): 2373–2378. doi:10.2217/nnm-2019-0058.
  • Goudarzi, M., D. Ghanbari, M. Salavati-Niasari, and A. Ahmadi. 2016. “Synthesis and Characterization of Al(OH)3, Al2O3 Nanoparticles and Polymeric Nanocomposites.” Journal of Cluster Science 27 (1): 25–38. doi:10.1007/s10876-015-0895-5.
  • Hermenean, A., C. Popescu, A. Ardelean, M. Stan, N. Hadaruga, C. V. Mihali, M. Costache, and A. Dinischiotu. 2012. “Hepatoprotective Effects of Berberis vulgaris L. Extract/β Cyclodextrin on Carbon Tetrachloride-Induced Acute Toxicity in Mice.” International Journal of Molecular Sciences 13 (7): 9014–9034. doi:10.3390/ijms13079014.
  • Hoshyar, N., S. Gray, H. Han, and G. Bao. 2016. “The Effect of Nanoparticle Size on in vivo Pharmacokinetics and Cellular Interaction.” Nanomedicine 11 (6): 673–692. doi:10.2217/nnm.16.5.
  • Jain, R. K., and T. Stylianopoulos. 2010. “Delivering Nanomedicine to Solid Tumors.” Nature Reviews Clinical Oncology 7 (11): 653–664. doi:10.1038/nrclinonc.2010.139.
  • Kawashima, R., F. Kawakami, T. Maekawa, H. Yamamoto, W. Koizumi, and T. Ichikawa. 2015. “Elemental Diet Moderates 5-Fluorouracil-Induced Gastrointestinal Mucositis Through Mucus Barrier Alteration.” Cancer Chemotherapy and Pharmacology 76 (2): 269–277. doi:10.1007/s00280-015-2790-z.
  • Khan, S., and N. Anwar. 2019. “Highly Porous pH-Responsive Carboxymethyl Chitosan-Grafted-Poly (Acrylic Acid) Based Smart Hydrogels for 5-Fluorouracil Controlled Delivery and Colon Targeting.” International Journal of Polymer Science 2019: 1–15. doi:10.1155/2019/6579239.
  • Lee, H. S., H. J. Cho, R. Yu, K. W. Lee, H. S. Chun, and J. H. Y. Park. 2014. “Mechanisms Underlying Apoptosis-Inducing Effects of Kaempferol in HT-29 Human Colon Cancer Cells.” International Journal of Molecular Sciences 15 (2): 2722–2737. doi:10.3390/ijms15022722.
  • Legaz, S., J. Y. Exposito, C. Lethias, B. Viginier, C. Terzian, and B. Verrier. 2016. “Evaluation of Polylactic Acid Nanoparticles Safety Using Drosophila Model.” Nanotoxicology 10 (8): 1136–1143. doi:10.1080/17435390.2016.1181806.
  • Logan, R. M., A. M. Stringer, J. M. Bowen, R. J. Gibson, S. T. Sonis, and D. M. Keefe. 2009. “Is the Pathobiology of Chemotherapy-Induced Alimentary Tract Mucositis Influenced by the Type of Mucotoxic Drug Administered?” Cancer Chemotherapy and Pharmacology 63 (2): 239–251. doi:10.1007/s00280-008-0732-8.
  • Longley, D. B., D. P. Harkin, and P. G. Johnston. 2003. “5-Fluorouracil: Mechanisms of Action and Clinical Strategies.” Nature Reviews Cancer 3 (5): 330–338. doi:10.1038/nrc1074.
  • Ma, Z., R. Ma, X. Wang, J. Gao, Y. Zheng, and Z. Sun. 2019. “Enzyme and PH Responsive 5-Flurouracil (5-FU) Loaded Hydrogels Based on Olsalazine Derivatives for Colon-Specific Drug Delivery.” European Polymer Journal 118: 64–70. doi:10.1016/j.eurpolymj.2019.05.017.
  • Macdonald, J. S. 1999. “Toxicity of 5-Fluorouracil.” Oncology 13 (7 Suppl 3): 33–34.
  • Mahaling, B., M. Verma, G. Mishra, S. Chaudhuri, D. Dutta, and S. Sivakumar. 2020. “Fate of GdF3 Nanoparticles-Loaded PEGylated Carbon Capsules Inside Mice Model: A Step Toward Clinical Application.” Nanotoxicology 14 (5): 577–594. doi:10.1080/17435390.2019.1708494.
  • Majtnerová, P., and T. Roušar. 2018. “An Overview of Apoptosis Assays Detecting DNA Fragmentation.” Molecular Biology Reports 45 (5): 1469–1478. doi:10.1007/s11033-018-4258-9.
  • Manzano, M.,. P. Bueno, R. Rueda, C. L. Ramirez-Tortosa, P. A. Prieto, and J. M. Lopez-Pedrosa. 2007. “Intestinal Toxicity Induced by 5-Fluorouracil in Pigs: A New Preclinical Model.” Chemotherapy 53 (5): 344–355. doi:10.1159/000107724.
  • Mhaidat, N. M., M. Bouklihacene, and R. F. Thorne. 2014. “ 5-Fluorouracil-Induced Apoptosis in Colorectal Cancer Cells Is Caspase-9-Dependent and Mediated by Activation of Protein Kinase C-δ.” Oncology Letters 8 (2): 699–704. doi:10.3892/ol.2014.2211.
  • Mousavi-Kamazani, M.,. M. Salavati-Niasari, M. Goudarzi, and Z. Zarghami. 2017. “Hydrothermal Synthesis of CdIn2S4 Nanostructures Using New Starting Reagent for Elevating Solar Cells Efficiency.” Journal of Molecular Liquids 242: 653–661. doi:10.1016/j.molliq.2017.07.059.
  • Nair, L., S. Jagadeeshan, S. A. Nair, and G. V. Kumar. 2011. “Biological Evaluation of 5-Fluorouracil Nanoparticles for Cancer Chemotherapy and Its Dependence on the Carrier, PLGA.” International Journal of Nanomedicine 6: 1685–1697. doi:10.2147/IJN.S20165.
  • Naserzadeh, P., S. A. Mortazavi, K. Ashtari, E. Seydi, and J. Pourahmad. 2018. Evaluation of the toxicity effects of silk fibroin on isolated fibroblast and Huvec cells. Iranian Journal of Pharmaceutical Research 17: 134.
  • Nita, M. E., H. Nagawa, O. Tominaga, N. Tsuno, S. Fujii, S. Sasaki, C. Fu, T. Takenoue, T. Tsuruo, and T. Muto. 1998. “5-Fluorouracil Induces Apoptosis in Human Colon Cancer Cell Lines with Modulation of Bcl-2 Family Proteins.” British Journal of Cancer 78 (8): 986–992. doi:10.1038/bjc.1998.617.
  • Osman, N. M., D. W. Sexton, and I. Y. Saleem. 2020. “Toxicological Assessment of Nanoparticle Interactions with the Pulmonary System.” Nanotoxicology 14 (1): 21–58. doi:10.1080/17435390.2019.1661043.
  • Pal, P., J. P. Pandey, and G. Sen. 2018. “Sesbania Gum Based Hydrogel as Platform for Sustained Drug Delivery: An ‘in vitro’ study of 5-Fu release.” International Journal of Biological Macromolecules 113: 1116–1124. doi:10.1016/j.ijbiomac.2018.02.143.
  • Patel, M. N., S. Lakkadwala, M. S. Majrad, E. R. Injeti, S. M. Gollmer, Z. A. Shah, S. H. S. Boddu, and J. Nesamony. 2014. “Characterization and Evaluation of 5-Fluorouracil-Loaded Solid Lipid Nanoparticles Prepared via a Temperature-Modulated Solidification Technique.” Aaps Pharmscitech 15 (6): 1498–1508. doi:10.1208/s12249-014-0168-x.
  • Pentak, D., W. W. Sułkowski, and A. Sułkowska. 2012. “Influence of Some Physical Properties of 5-Fluorouracil on Encapsulation Efficiency in Liposomes.” Journal of Thermal Analysis and Calorimetry 108 (1): 67–71. doi:10.1007/s10973-011-1822-0.
  • Perillo, B., M. Di Donato, A. Pezone, E. Di Zazzo, P. Giovannelli, G. Galasso, G. Castoria, and A. Migliaccio. 2020. “ROS in Cancer Therapy: The Bright Side of the Moon.” Experimental & Molecular Medicine 52 (2): 192–203. doi:10.1038/s12276-020-0384-2.
  • Pham, D. T., and W. Tiyaboonchai. 2020. “Fibroin Nanoparticles: A Promising Drug Delivery System.” Drug Delivery 27 (1): 431–448. doi:10.1080/10717544.2020.1736208.
  • Prabha, S., G. Arya, R. Chandra, B. Ahmed, and S. Nimesh. 2016. “Effect of Size on Biological Properties of Nanoparticles Employed in Gene Delivery.” Artificial Cells, Nanomedicine, and Biotechnology 44 (1): 83–91. doi:10.3109/21691401.2014.913054.
  • Pritchard, E. M., and D. L. Kaplan. 2011. “Silk Fibroin Biomaterials for Controlled Release Drug Delivery.” Expert Opinion on Drug Delivery 8 (6): 797–811. doi:10.1517/17425247.2011.568936.
  • Qi, Y., H. Wang, K. Wei, Y. Yang, R. Y. Zheng, I. S. Kim, and K. Q. Zhang. 2017. “A Review of Structure Construction of Silk Fibroin Biomaterials from Single Structures to Multi-Level Structures.” International Journal of Molecular Sciences 18 (3): 237. doi:10.3390/ijms18030237.
  • Radu, I. C., A. Hudita, C. Zaharia, P. O. Stanescu, E. Vasile, H. Iovu, M. Stan, et al. 2017. “Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-Rectal Cancer.” Frontiers in Pharmacology 8: 508. doi:10.3389/fphar.2017.00508.
  • Radu, I. C., A. Hudita, C. Zaharia, C. Negrei, GTaB. Dragomiroiu, D. E. Popa, M. Costache, et al. 2021. “Silk Fibroin Nanoparticles Reveal Efficient Delivery of 5-FU in a HT-29 Colorectal Adenocarcinoma Model in vitro.” Farmacia 69 (1): 113–122. doi:10.31925/farmacia.2021.1.15.
  • Rahmani, H., A. Fattahi, K. Sadrjavadi, S. Khaledian, and Y. Shokoohinia. 2019. “Preparation and Characterization of Silk Fibroin Nanoparticles as a Potential Drug Delivery System for 5-Fluorouracil.” Advanced Pharmaceutical Bulletin 9 (4): 601–608. doi:10.15171/apb.2019.069.
  • Rehm, Markus, Heiko Düßmann, Reiner U. Jänicke, Jeremy M. Tavaré, Donat Kögel, and Jochen H. M. Prehn. 2002. “Single-Cell Fluorescence Resonance Energy Transfer Analysis Demonstrates That Caspase Activation during Apoptosis is a Rapid Process. Role of Caspase-3.” Journal of Biological Chemistry 277 (27): 24506–24514. doi:10.1074/jbc.M110789200.
  • Ribeiro, R. A., C. W. Wanderley, D. V. Wong, J. M. S. Mota, C. A. Leite, M. H. Souza, F. Q. Cunha, and R. C. Lima-Junior. 2016. “Irinotecan- and 5-Fluorouracil-Induced Intestinal Mucositis: Insights Into Pathogenesis and Therapeutic Perspectives.” Cancer Chemotherapy and Pharmacology 78 (5): 881–893. doi:10.1007/s00280-016-3139-y.
  • Rivas, C. J. M., M. Tarhini, W. Badri, K. Miladi, H. Greige-Gerges, Q. A. Nazari, SaG. Rodríguez, R. Á. Román, H. Fessi, and A. Elaissari. 2017. “Nanoprecipitation Process: From Encapsulation to Drug Delivery.” International Journal of Pharmaceutics 532 (1): 66–81. doi:10.1016/j.ijpharm.2017.08.064.
  • Rubenstein, E. B., D. E. Peterson, M. Schubert, D. Keefe, D. Mcguire, J. Epstein, L. S. Elting, et al. 2004. “Clinical Practice Guidelines for the Prevention and Treatment of Cancer Therapy-Induced Oral and Gastrointestinal Mucositis.” Cancer 100 (9 Suppl): 2026–2046. doi:10.1002/cncr.20163.
  • Saegusa, Y., T. Ichikawa, T. Iwai, Y. Goso, I. Okayasu, T. Ikezawa, N. Shikama, K. Saigenji, and K. Ishihara. 2008. “Changes in the Mucus Barrier of the Rat During 5-Fluorouracil-Induced Gastrointestinal Mucositis.” Scandinavian Journal of Gastroenterology 43 (1): 59–65. doi:10.1080/00365520701579662.
  • Sargent, Daniel J., Silvia Marsoni, Genevieve Monges, Stephen N. Thibodeau, Roberto Labianca, Stanley R. Hamilton, Amy J. French, et al. 2010. “Defective Mismatch Repair as a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer.” Journal of Clinical Oncology 28 (20): 3219–3226. doi:10.1200/JCO.2009.27.1825.
  • Sasu, A., H. Herman, T. Mariasiu, M. Rosu, C. Balta, N. Anghel, E. Miutescu, C. Cotoraci, and A. Hermenean. 2015. “Protective Effects of Silymarin on Epirubicin-Induced Mucosal Barrier Injury of the Gastrointestinal Tract.” Drug and Chemical Toxicology 38 (4): 442–451. doi:10.3109/01480545.2014.992072.
  • Siegel, R. L., K. D. Miller, A. G. Sauer, S. A. Fedewa, L. F. Butterly, J. C. Anderson, A. Cercek, R. A. Smith, and A. Jemal. 2020. “Colorectal Cancer Statistics.” CA Cancer Journal for Clinicians 70 (3): 145–164. doi:10.3322/caac.21601.
  • Sun, X., C. Liu, A. Omer, W. Lu, S. Zhang, X. Jiang, H. Wu, D. Yu, and X. K. Ouyang. 2019. “pH-Sensitive ZnO/Carboxymethyl Cellulose/Chitosan Bio-Nanocomposite Beads for Colon-Specific Release of 5-Fluorouracil.” International Journal of Biological Macromolecules 128: 468–479. doi:10.1016/j.ijbiomac.2019.01.140.
  • Sung, H., J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray. 2021. “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.” CA Cancer J Clin 71 (3): 209–249. doi:10.3322/caac.21660.
  • Vibe, C. B., F. Fenaroli, D. Pires, S. R. Wilson, V. Bogoeva, R. Kalluru, M. Speth, E. Anes, G. Griffiths, and J. Hildahl. 2016. “Thioridazine in PLGA Nanoparticles Reduces Toxicity and Improves Rifampicin Therapy Against Mycobacterial Infection in Zebrafish.” Nanotoxicology 10 (6): 680–688. doi:10.3109/17435390.2015.1107146.
  • Vodenkova, S., T. Buchler, K. Cervena, V. Veskrnova, P. Vodicka, and V. Vymetalkova. 2020. “5-fluorouracil and Other Fluoropyrimidines in Colorectal Cancer: Past, Present and Future.” Pharmacology & Therapeutics 206: 107447. doi:10.1016/j.pharmthera.2019.107447.
  • Walsh, J. G., S. P. Cullen, C. Sheridan, A. U. Lüthi, C. Gerner, and S. J. Martin. 2008. “Executioner Caspase-3 and Caspase-7 Are Functionally Distinct Proteases.” Proceedings of the National Academy of Sciences of the United States of America 105 (35): 12815–12819. doi:10.1073/pnas.0707715105.
  • Yang, T., M. Aimaiti, D. Su, W. Miao, B. Zhou, D. Maimaitiyiming, A. Yusup, H. Upur, and A. Aikemu. 2017. “Enhanced Efficacy with Reduced Toxicity of Chemotherapy Drug 5-Fluorouracil by Synergistic Treatment with Abnormal Savda Munziq from Uyghur Medicine.” BMC Complementary and Alternative Medicine 17 (1): 201. doi:10.1186/s12906-017-1685-4.
  • Yao, Q., X. Ye, L. Wang, J. Gu, T. Fu, Y. Wang, Y. Lai, et al. 2013. “Protective Effect of Curcumin on Chemotherapy-Induced Intestinal Dysfunction.” The International Journal of Clinical and Experimental Pathology 6: 2342–2349.
  • Yavuz, B., L. Chambre, and D. L. Kaplan. 2019. “Extended Release Formulations Using Silk Proteins for Controlled Delivery of Therapeutics.” Expert Opinion on Drug Delivery 16 (7): 741–756. doi:10.1080/17425247.2019.1635116.
  • Zhang, X., D. Zhu, Y. Cheng, X. Zhang, X. Guo, N. Lin, and B. Zuo. 2021. “Preparation and Biocompatibility Characterization of Regenerated Silk Fibroin Films.” Journal of Macromolecular Science, Part B: 1–13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.